InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by King Rachel K., Director. Director active across 1 companies, notably NOVAVAX INC. In total, 7 filings have been logged. Total volume traded: €161k. The latest transaction was filed on 19 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
700 shares
Common Stock
SEC:0001209191-22-038593:0·
3,450 shares
Common Stock
SEC:0001209191-21-052810·
3,450 shares
Common Stock
SEC:0001209191-21-052810:0·
6,900 shares
Common Stock
SEC:0001209191-21-043702·
6,900 shares
Common Stock
SEC:0001209191-21-043702:0·
€80,300700 shares@ €114.71430.0054% mcap100.0% of flow
Common Stock
SEC:0001209191-21-035008·
Ideal exit: 13 Feb 2022 (T+270)
€80,300700 shares@ €114.71430.0054% mcap50.0% of flow
Common Stock
SEC:0001209191-21-035008:0·
Ideal exit: 13 Feb 2022 (T+270)
7 of 7 declarations
About King Rachel K.
Rachel K. King is a Board Member at Novavax Inc. She plays a key role in the governance of the company, contributing to the definition of its strategy and guiding its research efforts. Her experience in the biopharmaceutical sector is valuable in guiding Novavax in its vaccine development initiatives.
